PPT-Pre- and Post-Exposure Prophylaxis for HIV

Kevin L Ard MD MPH October 20 2016 Learning objectives Summarize the indications for and management of pre and postexposure prophylaxis Understand clinical uncertainties in preexposure prophylaxis management. Reducing the Risk. <Name of session> . DATE. Objectives. Define venous thromboembolism. Heighten awareness. the impact of VTE. the preventable nature of VTE. Discuss importance of . VTE risk assessment. for HIV PreventionMay 2014Fast Facts Pre-exposure prophylaxis, or PrEP, is a way to help prevent HIV by taking a pill every day. People who are at substantial risk for HIV should talk to their doctor PrEP. ). Yuma Health District 5/23/16. Alyssa Guido, MPH. Program Director, Arizona AETC. Arizona AIDS Education and Training Center. This . project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under . Settings. Ramona Bhatia, MD. Tuberculosis (TB). Epidemiology. Diagnostics and treatment. Prevention and student health issues . Malaria. Epidemiology. Diagnostics and treatment. Prophylaxis for travelling students. Integrating Pre-Exposure Prophylaxis ( PrEP ) into the Primary Care Setting Christine Kerr, MD Medical Director of HIV, Hepatitis, and Specialty Care Hudson River HealthCare February 12, 2016 Why 1of 2PageCreated 9/2019ecommendations for Persons Exposed to MeaslesaIG can be administered intramuscularly IGIM or intravenously IGIV Please check references available at https//wwwcdcgov/measles/ind NURS RESEARCH POROJECT PROPOSA. NURS 503. Name:…………. Ana G Mendez University. Facilitator: Nancy Woelki . DNP, APRN, MSN, RN. Date:………... The purpose of this research was to evaluate the advantage and disadvantage using of PrEP for HIV-negative adults with high risk for HIV.. to a potentially fatal B virus encephalomyelitis. We describe a decision tool for evaluating the need for antiviral post - exposure prophylaxis and provide a retrospective review of the injuries as Monoclonal Antibody Therapy What are monoclonal antibodies? Monoclonal antibodies (mAbs) are developed in a laboratory to mimic natural antibodies produced by the immune system. mAbs are administered rapid progressive & highly fatal viral disease of CNS caused by Lyssavirus type 1. .. Zoonotic . disease of warm blooded animals (dogs, cats , bats, racoons, skunks, foxes ) . Transmitted . to man by bite of rabid animal. Courses in Therapeutics and Disease State Management. Learning Objectives (Slide 1 of 3). Differentiate between influenza A and influenza B. List the primary subtypes of influenza A that are currently circulating. , PEP, PREP . Compiled by Jason Vermaak, . Ektha. . govind. and . Anjana. Thomas. Opportunistic infection In HIV. Opportunistic infections are those that occur more frequently in immunocompromised populations and are often more clinically severe in this group of people.. to Prevent Bacterial Sexually . Transmitted Infections. www.hivguidelines.org. September 2023. NYSDOH AIDS Institute Clinical Guidelines Program. Purpose of This Guideline. The goals of this guideline are to:. Implemented in Public Health Settings in Los Angeles. Jennifer N Sayles, MD, MPH, Gary P García, MPH, Rosemary C Veniegas, PhD, Robert K Bolan, MD, Wilbert C Jordan, MD, and Raphael J Landovitz, MD, MsC.